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Abstract 
The aim of this development is to optimize a bone substitute (BS) for use in tissue engineering. This is achieved through the 
combination of three phases in a biocomposite (BCO), in which each is reabsorbed in the site of implantation and replaced by 
autologous bone (patient's own). The inorganic phases are composed of irregular particles (150-300 microns) obtained by milling 
and sieving of a biphasic bioceramic (BC) of hydroxyapatite (HA of bovine origin) with 40 % (wt.) E-tricalcium phosphate (E- 
TCP, obtained by chemical synthesis) and Bioglass type 45S5 (45SiO2 -24,5CaO - 24,5Na2O - 6P2O5, in % wt.). Instead, the 
organic phase consists of collagen extracted from Wharton's jelly (part of the human embryonic tissue) from physical and 
chemical self-developed process. The BC is produced by mixture of HA and E-TCP (< 45ȝm) and molding by gelcasting with 
albumin in aqueous solutions, drying and sintering at 1200°C for 2 hours. The BG is obtained from the mixture of the oxides, 
melting at 1350°C and cast onto metal. Each phase and BCO is subjected to studies by electron microscopy (SEM and EDS), X-
ray diffraction (DRX) and infrared spectrometry (FT-IR). The biocompatibility is evaluated by in vivo studies using the laminar 
implant model in Wistar rats (n=40). Histological samples show high biocompatibility and ability to integrate with the bone 
tissue.  30 days after implantation, the material is completely reabsorbed and the bone regeneration process starts, the primary 
objective. The process developed allows the synthesis of a new BS with excellent biological properties for clinical use. 
© 2015 The Authors. Published by Elsevier Ltd. 
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1. Introduction 
Bone is a dynamic type of specialized and highly vascularized connective tissue, which consists of 70% mineral 
phase and 30% of organic phase. The first consists of hydroxyapatite (HA, Ca10(PO4)6(OH)2), a crystalline calcium 
phosphate that provides high stiffness and compressive strength to bone tissue. In contrast, the second is mostly type 
I collagen, a fibrillar protein that gives tensile strength and flexural strength.  
The bone can be injured in several clinical situations (cysts, tumors, hormonal diseases or trauma), generating 
bone defects, which can be repaired by the body, with the activity of bone-forming cells (osteoblasts). However, 
bone tissue engineering (BTE) must be required, when the defect exceeds a certain critical size and regeneration is 
affected. The clinical demand increases with population growth and BTE is applied in implant dentistry, 
craniofacial, plastic and orthopedic surgeries. Autologous bone graft remains the "gold standard", because of its 
biological propertiesൌ osteoconductive (provides the ideal environment for cell proliferation), osteoinductivity 
(promotes tissue formation), and osteogenesis. However, its limitation arises from the need for a donor site, which 
means prolonging patient rehabilitation, increases the risk of infection and morbidity. BTE is based on three pillars: 
the use of three-dimensional matrices or scaffolds, cells and biomolecular signals, with the ultimate goal of 
regenerating bone tissue by Martinez et al. (2012).  
The scaffolds are based on BTE, and they must be able to be replaced by host tissue, be porous, to allow 
vascularization and not to cause immunogenic response in the patient. The synthesis of matrices has used various 
synthetic biodegradable polymers (polylactic acid, polyglycolic, polyvinyl alcohol or combination thereof, etc.), 
limited by its low mechanical strength and hydrolysis in the biological medium, leaving acid residues. Also, natural 
polymers are used (polysaccharides such as alginates, chitin, cellulose compounds, etc.) and proteins (collagen, silk, 
etc.), which are considered as the most important today. Collagen has excellent biocompatibility, providing 
structural support to the repair process. However, its mechanical behavior is poor, because it is often combined with 
reinforcing inorganic phases by Pek et al. (2008). 
The above limitations have motivated this work, where it is proposed the use of bioceramic particles, BC, and 
bioactive glass, BG, scattered in a biological matrix. Inorganic phases chosen are known for their osteoconductive 
capacity (Martinez et al. (2012)), in the case of BC, HA + 40% ȕ-TCP (ȕ-tricalcium phosphate, ȕ-Ca3(PO4)2), with a 
degradation rate according to biological time. Instead, BG, with a composition close to BioglassTM (Pek et al. (2008)) 
exhibits osteoinductivity ability (Yuan et al. (2001)), related to the stimulation of certain genes, which increase the 
population of osteoblasts in the bone defect site. In addition, BG is capable of forming surfaces that can establish 
chemical bond with bone.  
Moreover, the selected source of collagen is the Wharton's jelly, WJ, which is the extracellular matrix of the 
umbilical cord of mammals. In addition, WJ is a major candidate to enhance the regenerative capacity, because of it 
is rich in growth factors by Nekanti et al. (2010) and Taghizadeh et al. (2011).  
The combination of above phases should produce a synergistic effect in relation to the biological and mechanical 
behavior, resulting in a bone tissue-like biocomposite, BCO. This concept is based on biomimetics (Pek et al. 
(2006)), in order to be adapted to the requirements of the organism and clinical application. This work is 
unprecedented in the known literature, and seeks to enhance the regenerative capacity of each phase. 
2. Experimental Procedure 
2.1 6\QWKHVLVDQG&KDUDFWHUization of Inorganic Phases 
HA is obtained from fresh bovine bone with an identifiable traceability. The bone is cut into 5-20 cm3 pieces, 
subjected to a chemical wash for removal of hemoglobin content and adipose tissue. This process is repeated by 
immersion in aqueous solutions at 40°C with ammonium bicarbonate (NHΏHCOΎ, at 4% in wt.), sodium hydroxide 
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(NaOH at 5% in wt.), hydrogen peroxide (H2O2 at 1% wt.) and acetic acid (C2H4O2 at 1% wt.), technical grade 
products (Química Oeste, Argentina), with periodic renewal of the solutions for 48 hs. The degreased and free of 
blood bone is dried under forced hot air flow (with centrifugal blower) within a vertical metal muffle provided with 
electrical heaters. There, the remaining collagen is subjected to pyrolysis at temperatures of 250-500°C for 3 hs., 
leaving a product covered with a carbon film, which is oxidized in an electric furnace at 900 °C for 3 hs. The result 
is spongy and cortical white bone, just constituted by HA according to phase analysis. This material is dried 
grounded in a ball mill (in 10 liters porcelain pot with 1 “diameter AISI 420 hardened steel balls) for 5 hs. The 
powder is manually screened to separate particle fractions of less than 45 μm size.  
The grains of ȕ-TCP phase are synthesized in Biomaterial Development and Innovation Center (Riga Technical 
University, Latvia) by means of modified chemical precipitation, by addition of an acid solution of H3PO4 to a 
suspension of Ca(OH)2, both products of analytical grade (Merck, Germany), maintaining the pH 6 at 22°C under 
constant agitation. The precipitate is filtered, oven dried, sintered at 1100°C for 2 hs., and ground and screened to 
the same procedure of the HA.  
Bioceramic, BC, is obtained by blending ȕ-TCP and HA powders, with 40% (in wt.) of first phase, they are 
made in ethyl alcohol fluid bed, by means of ball mill for 3 hs, (in airtight PVC flasks with 1 "diameter porcelain 
balls). The extracted mud is dried in an oven and subjected to light grinding. This powder is dispersed in a 15 % (in 
wt.) aqueous solution of egg albumin, maintaining a fraction of 50% (in wt.) of solid, and homogenized by stirring 
at 300 r.p.m. for 10 min. The obtained slurry is cast into silicone rubber molds, which are wrapped in PVC film, and 
immersed in a thermostatic bath, maintained at 90°C for 1 h. The gelled pieces (10 x 10 x 50 mm3) are oven dried, 
and finally taken to an electric furnace, where they are heated to 10°C min-1 up to the sintering temperature of 
1200°C for 2 hs., followed by cooling at slower rate to room temperature.  
Bioactive glass, BG, is obtained by mixing 45 g of SiO2, 43.32 g of CaCO3 of 38.01 g of Na2CO3, 30.27 g of 
Na2HPO4.2H2O, analytical grade (Anedra, Argentina) in a ball mill. This formulation is chosen to obtain a 
composition similar to 45S5 BioglassTM (45SiO2-24,5CaO-24,5Na2O-6P2O5 in mol %). This mixture is subjected to 
thermal cycle in an electric furnace inside 500 cm3 Pt crucible. The cycle is composed by heating at 10°C min-1 up 
to 1350°C (well above to glass melting point, close to 890°C), where it stays for 2 hs., and the molten material is 
cast onto a steel plate to produce rapid quenching. The BC and BG are grounded and screened in order to retain 150-
350 μm grains, adequate for no generation of post implantation inflammatory reactions. 
3UHSDUDWLRQRI%LRORJLFDO0DWUL[DQG%LRFRPSRVLWH%&2  
The biological matrix is extracted from the processing of human Wharton's jelly, WJ, following a series of 
physicochemical steps that are the result of own development, in the stage of a patent development. The placentas 
and umbilical cords are provided by the Carrillo Municipal Hospital, in agreement to a protocol approved by the 
Research and Ethics Committee. In general terms, the process includes steps of: hemoglobin washing (at -4°C), 
microbiological control, hydrolysis, inactivation, enrichment, esterification and de-ionization. The product is 
granulated from an aqueous solution into spray dry equipment, maintained at temperatures below 42°C. The entire 
process is conducted in sterile areas of a pharmacological laboratory to avoid contamination with pyrogens. The 
material is sterile packaged and stored in vacuum until its use. 
BC particles are dry blended with 5% (by weight) of BG and are dispersed in an aqueous solution of the 
processed WJ at 10% (in wt.), so that the proportion of inorganic solid is 30% (in wt.) of dispersion. The viscous 
mass is molded by injection through a syringe into the rubber moulds which allow obtaining blocks (3x18x18 mm3). 
Dehydration of the material is conducted by a forced flow of sterile filtered air for 24-48 hs., giving biocomposite 
stiff pieces, BCO. These parts are packaged in medical paper and polyethylene bags and sterilized with gamma 
irradiation dose of 10 kGy. 
The tenacity of the pieces of BCO is suitable for cutting with manual saw and preparing 1.5 x 1.5 x 6 mm3 
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micro-implants in the surgery room for implantation in rats. 
2.3 Structural and Chemical Characterization 
The BCO and its component phases are analyzed by means of the following techniques:  
The microstructures of BC, BG and BCO were analyzed by a scanning electron microscope (SEM, Zeiss Supra 
model 40, Germany), including the local chemical analysis by energy dispersive spectroscopy on Ag plated samples 
(EDS, 2[IRUG ,QVWUXPHQWV, UK). The identification of the crystalline phases was performed by X-ray diffraction 
(XRD, Rigaku, Japan) using CuKD radiation (Ȝ = 0.1542 nm) with Ni filter, a vertical goniometer using a 2T angle 
range of 20-70°, with a step of 0.2°.  
The chemical nature of bonds were studied by infrared Fourier transform spectroscopy (FT-IR, Perkin-Elmer, 
model Frontier®, USA) in the range of 400-4000 cm-1 after 250 scans: Granular samples were mixed KBr crystals, 
transparent to infrared radiation, in ratios smaller than 1% (in wt.), for measuring the absorbance. 
2.4 ,QYLYRDVVD\VDQGKLVWRORJLFDOSURFHVVLQJ 
40 male Wistar rats (150 ± 5) g body weight were used for the tests, which were fed ad libitum, following 
guidelines established by the National Institutes of Health (USA) for the use and care of laboratory animals (NIH 
1985) and the guidelines of the Faculty of Dentistry, Buenos Aires University  (Res. 352/02 and 694/02 CD).  
The animals were anesthetized with a solution of 8 mg of ketamine hydrochloride (Ketalar ®, Parke-Davis, 
USA) and 1.28 mg of Xylacina (Rompun, Bayer, Germany) per 100 mg of body weight. Both tibiae were shaved in 
the area of the tibial ridge with electric shaver, making an incision (approximately 1.5 cm. long) to the same level 
with a scalpel blade. The subcutaneous tissue, muscles and ligaments were dissected in order to expose the lateral 
aspect of the tibia in the diaphyseal area. A 1.5 mm diameter bore was made with a round bur by manual rotation, in 
order to prevent overheating and subsequent tissue necrosis. The implementation methodology employed is the 
"laminar implant test" described by Cabrini, where BCO micro-implants were introduced into both tibiae, parallel to 
the major axis of each, to be processed in two different ways. The procedure was finished with spaced point sutures 
without employing antibiotics.  
The animals were sacrificed by an overdose of anesthetic, in groups of 10 to 7, 14 and 30 days post-implantation. 
The tibiae were resected and fixed in formalin solution 10%, and imaged. They were included in methyl 
methacrylate and paraffin. They were sectioned manually with a saw, at the level of BCO implantation area, making 
three slices (approximately 500 μm thick) perpendicular to the long axis of the tibia. Histological sections were 
obtained by grinding to obtain sheets of 50-70 μm thick, through a lens grinding machine (Silmar Optical Products, 
Argentina), and finished with water sandpaper AX-51 (Abrasives Argentinos SAIC) and glycerin, to a suitable 
surface finish. Three sections from each tibia were colored with 1% Toluidine blue - technical sodium borate 
solution and fixed with 5% ammonium molybdinate solution. The examination montage was made with analytical 
grade glycerin (Merck Chemical, Argentina), employing a light microscopy (20&DUO =HLVV, Axioskop 2 MOT 
model, Germany). The remaining cuts were vacuum metalized with 20 nm Ag film for study by SEM and EDS.  
3.  Results and discussion 
3.1 Structural and Chemical Characterization  
XRD analysis of BG and BC confirms the crystalline and amorphous nature, respectively (Fig.1).  BC is 
composed of HA (file 34-0010) and E-TCP (file 55-0898) phases. Instead, BG has a single broad peak centered at 
31.8° corresponding to SiO2 (file 05-0492) (ICDD (2005)), with no evidence of other oxides, whose elements are 
detected by EDS. 
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Fig. 1.  Diffractograms of BC (up) and BG (beneath). 
Analysis of FT-IR spectra of BC shows the predominant presence of the group PO43- in the band 960-1109 cm-1, 
and 602, 565 and 475 cm-1 (Guo et al. (2013) and Sha et al. (2011)); while the OH-group .is in 3573 (Guo et al. 
(2013)) and Scalera et al. (2013)), 872 and 631 cm-1 (Guo et al. (2013)). In contrast, the spectrum of BG presents 
only some peaks that can be associated with the nominal composition of Bioglass, although the spectrum is rich in 
absorption peaks (Fig.2). The vibrations of the PO2 group can be seen at 1416 and 1445 cm-1 (Qian et al. (2009)), 
and a trace PO vibration at 595 cm-1 (Ma et al. (2010)), while those associated with Si-O-Si amorphous silicate are 
visible at 1092 and 451 cm-1 (Qian et al. (2009) and Ma et al. (2010)).  
The biological matrix exhibits the functional groups of the amides, characteristic of the macro-molecules of the 
poly-peptide's own collagen type I and II. Thus,  amide I is present at 1656 and 1159 cm-1 (Boryskina et al. (2011)),  
II in 1539 cm-1 (Xu et al. (2010)), III in 1452 and 1244 cm-1 (Campos Vidal et al. (2011)), A at 3468 cm-1 and B at 
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2968 cm-1 (Campos Vidal et al. (2011)). Other functional groups (CH3, CH2, CH) can contribute to the absorption at 
1339 cm-1 (Boryskina et al. (2011)), being the least clear association at 1090 cm-1, further, may correspond to the 
vibrational states of C-C and C N (Boryskina et al. (2011)) (Fig.2). However, such information is not enough to say 
that the collagen matrix is present and therefore most likely corresponds to isolated poly-peptide chains resulting 
from the denaturation caused by chemical treatments of WJ. 
The FT-IR analysis of BCO shows overlapping absorption peaks and bands of BC phases and biological matrix, 
which were individually detected before. The interaction between BC crystals and biological matrix, probably 
containing some amino acid residues of the poly-peptide chains, could be attributed to the phosphate band between 
980 and 1150 cm-1 (Chang et al. (2003)) (Figs. 2-3). The presence of BG in BCO is not discernible in any case, 
because of its low concentration of BG (5% by weight of the mixture of inorganic particles). However, BG particles 
are individualized in the EDS spectra and in histological sections observed by SEM (Fig. 4). In addition, they 
exhibit BC particles partially reabsorbed in implanted BCO. 
Fig. 2. FT-IR spectra of bioceramic (left) and bioglass (rigth). 
Fig. 3. FT-IR spectra of biological matrix (left) and biocomposite (rigth). 
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3.2 Biological Response 
BCO has excellent biocompatibility, unremarkable in postoperative immediate and mediate stages (inflammatory
reactions). Radiographic studies showed the presence of BCO at the site of implantation in all tibias, whose
radiopacity decreases with implementation time, indicating the progressive resorption as the bone is regenerated, as
shown in Fig. 5. In addition, it is found no trace of the original incision on the surface of tibia after 30 days of
implantation. 
 
Fig. 4. BCO matrix with BC and BG particles 
Histological sections did not detect the presence of inflammatory infiltrate in the evaluated experimental times 
(7, 14, 30 days post-implantation). The persistence of residual clot is observed in the implantation of BCO, and the 
presence of trabecular bone and reticular tissue, 7 days after implantation. Moreover, the persistence of particles of 
irregular morphology of BC and BG is visible, seeming that BC grains reabsorption occurs more rapidly, as shown 
in Fig.6. Laminar bone tissue is surrounding BG and BG particles, forming continuous and intimate adaptation 
morphology interface, from post-implantation 14th day. The volume of bone tissue grows over time in the BCO 
implantation.  
3. Conclusions 
The work demonstrates the technological feasibility of producing composites with high capacity for bone 
regeneration. These integrate Wharton's jelly biological matrix with bioceramics and bioglass particles, a 
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combination that is unprecedented in the literature. These results will be validated by clinical trials in humans, and 
allow the production of bone substitutes in the country in order to replace imported commercial products with 
comparable clinical response. 
 
Fig. 5. Tibial radiographs of immediate 
and 30 days after implantation. 
Fig. 6.  Histological section showing the partially disaggregated BC particles, BG particles, 
and formed bone tissue at 30 days of implantation. 
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